Umbilical Cord Mesenchymal Stem Cells and Wnt Pathway Modulation: A Novel Therapy for Liver Cirrhosis and Steatosis

Key Points

• Liver cirrhosis and steatosis show significant improvement with umbilical cord mesenchymal stem cell therapy.
• 45% reduction in liver steatosis severity observed after treatment using this innovative approach.
• Analysis of cellular interactions in the Wnt pathway highlights potential mechanisms for therapeutic benefits.
• Highlights the need for further studies on clinical applications and long-term outcomes after mesenchymal stem cell therapy.